Morgan Joseph Starts Ironwood Pharmaceuticals (IRWD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $3.60 +0.28%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 7
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 7
Join SI Premium – FREE
Morgan Joseph initiates coverage on Ironwood Pharmaceuticals (NASDAQ: IRWD) with a Buy. PT $20.00.
For more ratings news on Ironwood Pharmaceuticals click here and for the rating history of Ironwood Pharmaceuticals click here.
Shares of Ironwood Pharmaceuticals closed at $12.26 yesterday.
For more ratings news on Ironwood Pharmaceuticals click here and for the rating history of Ironwood Pharmaceuticals click here.
Shares of Ironwood Pharmaceuticals closed at $12.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Glencore Plc (GLC:AU) (GLCNF) at Buy
- Citizens Starts Vail Resorts (MTN) at Market Perform
- Goldman Sachs Starts Gold Fields Ltd. (GFI:SJ) (GFI) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan JosephSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
